Data as of Mar 14
| +4.43 / +4.01%|
The 3 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 144.00, with a high estimate of 149.00 and a low estimate of 125.00. The median estimate represents a +25.37% increase from the last price of 114.86.
The current consensus among 5 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.